Scarica l'app Stockscreener
5.06
3.25%
-0.17
Dopo l'orario di chiusura:
5.06
Ars Pharmaceuticals Inc Borsa (SPRY) Ultime notizie
SueWallSt Reminds ARS Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 5, 2026SPRY - PR Newswire
רוזן, יועץ למשקיעים מהימן, קורא למשקיעי ARS Pharmaceuticals, Inc. לשכור ייצוג משפטי לקראת מועד אחרון חשוב בתביעה הייצוגית בניירות הערך – SPRY - GlobeNewswire Inc.
SPRY EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds ARS Pha - The National Law Review
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ARS - GlobeNewswire
SPRY Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in ARS Pharmaceuticals Securities LawsuitContact Levi & Korsinsky - PR Newswire
Kaplan Fox Deadline Alert: ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Investors Have Until October 5, 2026 to Seek a Lead Plaintiff Role - newmediawire.com
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
symbol__ Stock Quote Price and Forecast - CNN
Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals Inc. Investors to Act: Class Action Filed Alleging Investor Harm - lincolnjournal.com
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit - The Conway Daily Sun
SPRY Stock Tanks Over 23% After-Hours — ARS Pharmaceuticals Reports No New Major Insurance Wins For Neffy - Stocktwits
SPRY Should I Buy - Intellectia AI
ROSEN, A TOP RANKED LAW FIRM, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionSPRY - ACCESS Newswire
Another ARS Pharma (NASDAQ: SPRY) insider stock sale is coming, with the size now disclosed - Stock Titan
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
Kaplan Fox Continues to Remind ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Investors of the Lead Plaintiff Deadline on October 5, 2026 - NewMediaWire
ARS Pharmaceuticals (SPRY) insider lines up Sept. 3 stock sale after August trades - Stock Titan
Faruqi & Faruqi, LLP Urges ARS Pharmaceuticals (SPRY) Investors t - The National Law Review
SPRY UPCOMING DEADLINE: SueWallSt Alerts ARS Pharmaceuticals Inc. Stockholders of Securities Class ActionContact the Firm - PR Newswire
Chief commercial officer at ARS Pharma (SPRY) gets 1.0M stock options - Stock Titan
Insider at ARS Pharmaceuticals (NASDAQ: SPRY) plans another stock sale - Stock Titan
ARS Stock Drop: Robbins LLP Reminds Investors They May Be Eligible to Lead the Class Action Against ARS Pharmaceuticals Inc. - TMX Newsfile
SPRY Shareholder Alert: ARS Pharmaceuticals Inc. Securities Class Action LawsuitInvestors Should Contact Levi & Korsinsky - PR Newswire
ARS Pharmaceuticals (SPRY) Institutional Ownership 2026 $SPRY - marketbeat.com
Kaplan Fox Continues to Alert Investors of a Securities Class Act - The National Law Review
Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on October 5, 2026 Against ARS Pharmaceuticals Inc. (NASDAQ: SPRY) - NewMediaWire
Repeat insider selling at ARS Pharma (SPRY) now includes a planned early-September trade - Stock Titan
Acurx Pharmaceuticals, Inc. SEC Filing (Sep 1, 2026) - Stock Titan
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences - The Manila Times
SPRY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
SPRY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
ROSEN, REGARDED INVESTOR COUNSEL, Encourages ARS - GlobeNewswire
ARS Pharma (NASDAQ: SPRY) insider lines up new sale after August stock disposals - Stock Titan
Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals - GlobeNewswire
SPRY Shareholder Alert: ARS Pharmaceuticals Inc. Securities - GlobeNewswire
SPRY CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds ARS Pharma - The National Law Review
ROSEN, NATIONAL TRIAL LAWYERS, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel ... - heraldandnews.com
Kaplan Fox Continues to Alert Investors of ARS Pharmaceuticals Inc. (NASDAQ: SPRY) to a Class Action Deadline on October 5, 2026 - The Globe and Mail
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming DeadlinesSPRY - PR Newswire
ARS PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. - globenewswire.com
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in ARS Pharmaceuticals Inc. LawsuitSPRY - Morningstar
Kaplan Fox Encourages ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Inv - The National Law Review
Levi & Korsinsky Reminds ARS Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 5, 2026SPRY - PR Newswire
ROSEN, NATIONAL TRIAL COUNSEL, Encourages ARS - GlobeNewswire
SPRY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub ... - Herald and News
Kaplan Fox Encourages ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Investors Seeking Recovery to Contact the Firm Before October 5, 2026 - barchart.com
ARS Pharma (SPRY) Cuts Spending As It Chases Neffy Market Share - Yahoo Finance
SPRY Investors Have Rights – If You Lost Money Investing in - GlobeNewswire
ARS Pharmaceuticals, Inc. (SPRY) LawsuitInvestors Urged to Contact Levi & Korsinsky Before October 5, 2026 - ACCESS Newswire
Faruqi & Faruqi, LLP Urges ARS Pharmaceuticals (NASDAQ: SPRY) Inv - The National Law Review
Tejara Capital Ltd Invests $4.86 Million in ARS Pharmaceuticals, Inc. $SPRY - MarketBeat
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with ... - heraldandnews.com
ARS Pharmaceuticals (SPRY) insider plans sale after Aug. 18–19 stock disposals - Stock Titan
ARS Pharma (SPRY) Q2 2026 Earnings Call Transcript - AOL.com
ARS Pharmaceuticals (NASDAQ: SPRY) holder plans 25K-share sale after 100K sold - Stock Titan
SPRY Investor Alert: ARS Pharmaceuticals Inc. Securities Class Action NoticeContact SueWallSt - PR Newswire
ARS Pharmaceuticals (NASDAQ:SPRY) Shares Down 6.3%What's Next? - MarketBeat
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):